Showing results (151-160 of 174) with videos related to

Sort By:
Pageof 18
Hepatology International|October 2, 2020
The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver diseaseMohammed Eslam, Shiv K Sarin, Vincent Wai-Sun Wong, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 9, 2023
Validation of the Blood Test MACK-3 for the Noninvasive Diagnosis of Fibrotic Nonalcoholic Steatohepatitis: An International Study With 1924 PatientsClémence M Canivet, Ming-Hua Zheng, Sami Qadri, et al.
The Lancet. Gastroenterology & Hepatology|October 8, 2020
Redefining fatty liver disease: an international patient perspectiveGamal Shiha, Marko Korenjak, Wayne Eskridge, et al.
Nature Genetics|April 11, 2017
IFN-λ3, not IFN-λ4, likely mediates IFNL3-IFNL4 haplotype-dependent hepatic inflammation and fibrosisMohammed Eslam, Duncan McLeod, Kebitsaone Simon Kelaeng, et al.
Cellular and Molecular Life Sciences : CMLS|March 25, 2022
Fibrotic activity quantified in serum by measurements of type III collagen pro-peptides can be used for prognosis across different solid tumor typesNicholas Willumsen, Christina Jensen, George Green, et al.
The Journal of Pathology|February 15, 2021
Dual proteotoxic stress accelerates liver injury via activation of p62-Nrf2Deniz Kuscuoglu, Lisa Bewersdorf, Kathrin Wenzel, et al.
Nature Communications|September 16, 2016
MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis CKhaled Thabet, Anastasia Asimakopoulos, Maryam Shojaei, et al.
Nature Communications|March 6, 2015
Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver diseaseMohammed Eslam, Ahmed M Hashem, Reynold Leung, et al.
Journal of Hepatology|November 24, 2015
FibroGENE: A gene-based model for staging liver fibrosisMohammed Eslam, Ahmed M Hashem, Manuel Romero-Gomez, et al.
Hepatology (Baltimore, Md.)|January 30, 2016
Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypesMohammed Eslam, Alessandra Mangia, Thomas Berg, et al.
Pageof 18